1 Floris AV, "α-glucosidase inhibitors for patients with type 2 diabetes" 28 : 154-162, 2005
2 Yagi M, "The structure of moranoline, a piperidine alkaloid from Morus species" 50 : 571-572, 1976
3 Asano N, "Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.)" 49 : 4208-4213, 2001
4 Wanlaya Naowaratwattana, "Phenolic-Containing Organic Extracts of Mulberry (Morus alba L.) Leaves Inhibit HepG2 Hepatoma Cells Through G2/M Phase Arrest, Induction of Apoptosis, and Inhibition of Topoisomerase IIα Activity" 한국식품영양과학회 13 (13): 1045-1056, 2010
5 Horton ES, "NIDDM-the devastating disease" 28 : S3-S11, 1995
6 Anno T, "Maltose, sucrase and a-amylase inhibitory activity of Morus leaves extract" 30 : 223-229, 2004
7 Miyahara C, "Inhibitory effects on mulberry leaf extract on postprandial hyperglycemia in normal rats" 50 : 161-164, 2004
8 Oku T, "Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity" 95 : 933-938, 2006
9 Castiglioni S, "Influence of steeping conditions (time, temperature, and particle size) on antioxidant properties and sensory attributes of some white and green teas" 66 : 491-497, 2015
10 Asano N, "Glycosidase inhibitors: update and perspectives on practical use" 13 : 93R-104R, 2003
1 Floris AV, "α-glucosidase inhibitors for patients with type 2 diabetes" 28 : 154-162, 2005
2 Yagi M, "The structure of moranoline, a piperidine alkaloid from Morus species" 50 : 571-572, 1976
3 Asano N, "Polyhydroxylated alkaloids isolated from mulberry trees (Morus alba L.) and silkworms (Bombyx mori L.)" 49 : 4208-4213, 2001
4 Wanlaya Naowaratwattana, "Phenolic-Containing Organic Extracts of Mulberry (Morus alba L.) Leaves Inhibit HepG2 Hepatoma Cells Through G2/M Phase Arrest, Induction of Apoptosis, and Inhibition of Topoisomerase IIα Activity" 한국식품영양과학회 13 (13): 1045-1056, 2010
5 Horton ES, "NIDDM-the devastating disease" 28 : S3-S11, 1995
6 Anno T, "Maltose, sucrase and a-amylase inhibitory activity of Morus leaves extract" 30 : 223-229, 2004
7 Miyahara C, "Inhibitory effects on mulberry leaf extract on postprandial hyperglycemia in normal rats" 50 : 161-164, 2004
8 Oku T, "Inhibitory effects of extractives from leaves of Morus alba on human and rat small intestinal disaccharidase activity" 95 : 933-938, 2006
9 Castiglioni S, "Influence of steeping conditions (time, temperature, and particle size) on antioxidant properties and sensory attributes of some white and green teas" 66 : 491-497, 2015
10 Asano N, "Glycosidase inhibitors: update and perspectives on practical use" 13 : 93R-104R, 2003
11 Kimura T, "Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in human" 55 : 5869-5874, 2007
12 Astill C, "Factors affecting the caffeine and polyphenol contents of black and green tea infusions" 49 : 5340-5347, 2001
13 Fernando CD, "Extraction kinetics of phytochemicals and antioxidant activity during black tea (camellia sinensis l.) brewing" 14 : 74-, 2015
14 Asai A, "Effect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism" 2 : 318-323, 2011
15 Vichasilp C, "Development of high 1-deoxynojirimycin (DNJ) content mulberry tea and use of response surface methodology to optimize tea-making conditions for highest DNJ extraction" 45 : 226-232, 2012
16 Kimura T, "Determination of 1-deoxynojirimycin in mulberry leaves using hydrophilic interaction chromatography with evaporative light scattering detection" 52 : 1415-1418, 2004
17 Shibano M, "Biosynthesis of 1-deoxynojirimycin in Commelina communis: A difference between the microorganisms and plants" 65 : 2661-2665, 2004
18 Vichasilp C, "A novel gelatin crosslinking method retards release of mulberry 1-deoxynojirimycin providing a prolonged hypoglycaemic effect" 134 : 1823-1830, 2012